172. Hypophosphatasia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 34 / Drugs : 17 - (DrugBank : 4) / Drug target genes : 3 - Drug target pathways : 6
Hypophosphatasia and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 172 | Hypophosphatasia |
| 270 | Chronic recurrent multifocal osteomyelitis |
| 286 | Hereditary sideroblastic anemia |
| 55 | Relapsing polychondritis |
| 43 | Microscopic polyangiitis |
| 326 | Osteopetrosis |
| 283 | Acquired pure red cell aplasia |
| 45 | Eosinophilic granulomatosis with Polyangiitis |
| 62 | Paroxysmal nocturnal hemoglobinuria |
| 44 | Wegener granulomatosis |
| 35 | Pemphigus |
| 284 | Diamond-Blackfan anemia |
| 40 | Takayasu arteritis |
| 42 | Polyarteritis nodosa |
| 285 | Fanconi anemia |
| 256 | Muscle glycogenosis |
| 331 | Idiopathic multicentric castleman disease |
| 162 | Pemphigoid |
| 41 | Giant cell arteritis |
| 164 | Oculocutaneous albinism |
| 93 | Primary biliary cholangitis |
| 56 | Behcet disease |
| 271 | Ankylosing spondylitis |
| 60 | Aplastic anemia |
| 11 | Myasthenia gravis |
| 50 | Dermatomyositis |
| 107 | Juvenile idiopathic arthritis |
| 53 | Sjogren syndrome |
| 19 | Lysosomal storage disease |
| 84 | Sarcoidosis |
| 34 | Neurofibromatosis |
| 65 | Primary immunodeficiency |
| 51 | Scleroderma |
| 49 | Systemic lupus erythematosus |
| 97 | Ulcerative colitis |
| 96 | Crohn disease |
| 46 | Malignant rheumatoid arthritis |
| 13 | Multiple sclerosis/Neuromyelitis optica |